Blog
Discover expert articles and perspectives on diagnosing and monitoring multiple myeloma, as well as insights into immune system disorders
Featured
Multiple myeloma diagnostic pathway: The laboratory's role
A national survey of U.S. primary care providers reveals gaps in multiple myeloma test selection - and how labs can support guideline-compliant testing.
Learn more
Multiple Myeloma Diagnosis & Monitoring: Key Insights from New CME Activity
Learn more
Challenges of running special protein tests on automated lines
Learn more
Understanding blood cancers and early detection
Learn more
Multiple myeloma diagnostic pathway: The laboratory's role
A national survey of U.S. primary care providers reveals gaps in multiple myeloma test selection - and how labs can support guideline-compliant testing.
Read more
Multiple Myeloma Diagnosis & Monitoring: Key Insights from New CME Activity
Explore guideline-based testing strategies for multiple myeloma diagnosis and surveillance - from SLiM-CRAB criteria to serum free light chain assays. Access the free Medscape CME.
Read more
Challenges of running special protein tests on automated lines
Special protein assays have requirements that can slow automated chemistry lines, increase manual steps, and affect turnaround times, maintenance, and reliability.
Read more
Guidelines for multiple myeloma testing
Discover key tests for early multiple myeloma diagnosis to help reduce delays, prevent complications, and improve patient outcomes and survival.
Read more
Multiple myeloma: Signs and symptoms
Recognizing risk factors and signs of multiple myeloma can guide timely referrals. Learn when to suspect myeloma in patients with nonspecific symptoms.
Read more
New perspectives on monoclonal proteins
See how the EXENT™ System pairs automated immunoprecipitation with MALDI-ToF mass spectrometry to detect and measure monoclonal proteins that SPE and IFE can miss.
Read more
Advancing protein diagnostics through scientific leadership
The Binding Site advances protein diagnostics through scientific leadership and innovation to address unmet needs in multiple myeloma and immune disorders.
Read more
Putting the significance in MGUS
Explore the significance of MGUS with insights from Dr. Ola Landgren on multiple myeloma from our ASH 2024 interview
Read more
Understanding blood cancers and early detection
Learn about blood cancers including leukemia, lymphoma, and multiple myeloma, and the importance of early detection.
Read more
Understanding light chains and the importance of sFLC testing in multiple myeloma
Light chains play a key role in myeloma. Learn how sFLC tests help assess their levels and ratios, aiding diagnosis and treatment decisions.
Read more